Capillary blood tests may overestimate ketosis: triangulation between three different measures of β-hydroxybutyrate.


Journal

American journal of physiology. Endocrinology and metabolism
ISSN: 1522-1555
Titre abrégé: Am J Physiol Endocrinol Metab
Pays: United States
ID NLM: 100901226

Informations de publication

Date de publication:
01 02 2020
Historique:
pubmed: 11 12 2019
medline: 6 5 2020
entrez: 11 12 2019
Statut: ppublish

Résumé

The ketone body β-hydroxybutyrate (BHB), assessed by a point-of-care meter in venous whole blood (BHBv), was used as the main outcome in a study on nutritional ketosis in healthy older adults. Two other BHB measures were also used in the study for validation and exploratory purposes, and here we report findings on correlation and agreement between those three methods. Ketosis in the range of 0-1.5 mmol/L was induced in 15 healthy volunteers by intake of medium-chain fatty acids after a 12-h fast. BHBv was assessed at 12 time points for 4 h. The same point-of-care meter was also used to test capillary blood (BHBc) at three time points, and a laboratory test determined total ketones (TK) in plasma (BHBp + acetoacetate) at four time points. A total of 180 cases included simultaneous data on BHBv, BHBc, BHBp, and TK. TK correlated with BHBp (Pearson's

Identifiants

pubmed: 31821040
doi: 10.1152/ajpendo.00454.2019
doi:

Substances chimiques

Fatty Acids 0
Ketones 0
3-Hydroxybutyric Acid TZP1275679

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

E184-E188

Commentaires et corrections

Type : ErratumIn

Auteurs

Jakob Norgren (J)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Shireen Sindi (S)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, United Kingdom.

Anna Sandebring-Matton (A)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Division of Neuro Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Ingemar Kåreholt (I)

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Institute of Gerontology, School of Health and Welfare, Aging Research Network - Jönköping, School of Health and Welfare, Jönköping University, Jönköping, Sweden.

Ulrika Akenine (U)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Karin Nordin (K)

Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.

Staffan Rosenborg (S)

Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.

Tiia Ngandu (T)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Department of Public Health Solutions, Public Health Promotion Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.

Miia Kivipelto (M)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, United Kingdom.
Department of Neurology, Institute of Clinical Medicine and Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Theme Aging, Karolinska University Hospital, Stockholm, Sweden.
Stockholms Sjukhem, Research and Development Unit, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH